Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Muhammad Rishi

Vascular Surgery Kettering, OH Medical Doctor

NPI 1063655165 CMS profile 5703175

3535 Southern Blvd, Ste 2000, Kettering, OH 45429

Open in the dashboard

General payments

$3,403

27 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Muhammad Rishi of Kettering, OH is reported in the CMS Open Payments database as having received $3,403 across 27 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 40th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $1,390 11
2023 General $1,119 9
2020 General $31 1
2019 General $863 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Muhammad Rishi
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Muhammad Rishi were reported at $0. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Muhammad Rishi Vascular Surgery median Middle half National median
2019 $863 $796 $226–$2,363 $163
2020 $31 $348 $118–$1,110 $114
2021 $0 $471 $158–$1,421 $132
2022 $0 $725 $222–$2,183 $149
2023 $1,119 $836 $257–$2,440 $160
2024 $1,390 $909 $252–$2,619 $164
2025 $0 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Medtronic, Inc. $1,367 10 payments
  2. Medtronic Vascular, Inc. $863 6 payments
  3. Cook Medical LLC $784 8 payments
  4. W. L. Gore & Associates, Inc. $183 1 payment
  5. Abbott Laboratories $174 1 payment
  6. Silk Road Medical, Inc. $31 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $1,855 16 payments
  2. Travel and Lodging $1,230 10 payments
  3. Education $318 1 payment
Products named General payments · program years 2019–2024
  1. ENDURANT IIS $1,198 9 payments
  2. Zenith $784 8 payments
  3. Endurant $545 5 payments
  4. GORE VIABAHN Endoprosthesis with Heparin $183 1 payment
  5. XACT $174 1 payment
  6. Heli-FX EndoAnchor System $169 1 payment
  7. ENROUTE Transcarotid Neuroprotection System $31 1 payment
  8. ENROUTE Transcarotid Stent System $31 1 payment
  9. ENHANCE Transcarotid Peripheral Access Kit $31 1 payment
  10. ENROUTE 0.014 Guidewire $31 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

675

Median for Vascular Surgery: 122

Drug cost

$113,864

Median for Vascular Surgery: $14,135

Branded share of claims

69.3%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 85 $82,555
Xarelto Rivaroxaban Brand 32 $27,398
Clopidogrel Clopidogrel Bisulfate Brand 282 $1,337
Pentoxifylline Generic 18 $617
Atorvastatin Calcium Generic 61 $527
Cilostazol Generic 23 $513
Gabapentin Generic 41 $356
Cephalexin Generic 17 $168
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 17 $137
Acetaminophen-Codeine Acetaminophen With Codeine Brand 36 $94

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 104 billing codes

Paid by Medicare

$148,670

Medicare's payments for the services billed

Medicare patients

487

Average age 74

Services billed

1,238

234 women, 253 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 60%
Ischemic heart disease 55%
Chronic kidney disease 48%
Diabetes 47%
Heart failure 41%
COPD 35%
Atrial fibrillation 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

27 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record